Clinical Trial Update: PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation [Phase 2]

View source ↗

Summary

Phase 2 PK study evaluating melphalan HCL and Alkeran for MA conditioning in autologous transplantation for multiple myeloma completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran for Injection (melphalan)
• Melphalan HCL (melphalan)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-08-20